• Go to navigation
  • Go to content
AstraZeneca

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca United States

Main navigation

  • Home
  • Our medicines
  • Diseases and conditions
  • Community support
    • Areas we support
    • Request a contribution
    • Contributions highlights
    • Contributions report
    • Good neighbors
    • Frequently asked questions
    • Healthcare solutions
  • Help affording your medicines
  • Research & development
  • Healthcare professionals
  • Careers
  • About AstraZeneca US

You are here

  • Home
  • Community support
  • Frequently asked questions

Answers to questions regarding our community support and commitment to transparency.

    • What is AstraZeneca’s position on transparency and its importance to the healthcare industry?
    • Why is AstraZeneca going public with its contributions?
    • What types of programs does AstraZeneca support?
    • How does AstraZeneca make contribution funding decisions?
    • How can nonprofit organizations apply for funding?
    • What is AstraZeneca’s approval process for contributions?
    • Does previous support of a program by AstraZeneca guarantee future support?
    • How does AstraZeneca ensure that contributions do not pose a conflict of interest with recipient organizations?
    • Does AstraZeneca have a commitment to transparency in other areas besides contributions?
    • What is AstraZeneca’s position on transparency and its importance to the healthcare industry?
      AstraZeneca believes it is important to be open about how we conduct our business and what we are doing to make a meaningful difference to patient health.  We believe in providing information to the public about our company, our products and how we do business as part of our commitment to corporate responsibility and to improving patient health.

      Back to top

    • Why is AstraZeneca going public with its contributions?
      AstraZeneca has a strong heritage of discovering and delivering medicines designed to improve the health of patients around the world managing a variety of medical conditions. While drug discovery and delivery is what we do, we also know that how we do business is important to the many people whose lives we touch, including patients, physicians, employees, investors and the communities around us. Maintaining the trust of those audiences is very important to us.

      Back to top

    • What types of programs does AstraZeneca support?

      AstraZeneca primarily supports programs and organizations whose mission and interests are aligned with our goal of improving patient health, the provision of healthcare and important health-related societal problems.  

      Highlights of the key initiatives we support can be found in the Community Support section of our Web site.

      Back to top

    • How does AstraZeneca make contribution funding decisions?

      Contributions are evaluated against an initial set of factors that include available funding resources, the scope of the project being funded, its impact on patient health, and its alignment to our patient health priorities.  While we support general health initiatives, we believe we can make the biggest impact by focusing our efforts in areas in which we have the greatest expertise including, cardiovascular disease, diabetes, gastrointestinal disorders, infectious disease, mental illness, and respiratory illness.  

      Back to top

    • How can nonprofit organizations apply for funding?

      Organizations can request a contribution on our Web site by filling out an application for a contribution. Priority is given to requests that focus on diseases or conditions relevant to the therapeutic areas where AstraZeneca has expertise and where we can make a meaningful difference to the health of patients in local communities. Having a positive impact on a community’s health is a core decisive factor for the company’s charitable giving and community support.  

      Back to top

    • What is AstraZeneca’s approval process for contributions?

      Non-profit organizations must have a 501c tax-exempt status and be in good standing with the Internal Revenue Service (IRS) before they can be approved for funding. Internally, we have a multi-tiered review and approval process, depending on the complexity of the request.  

      Priority is given to requests that focus on diseases or conditions relevant to the therapeutic areas where AstraZeneca has expertise and where we can make a meaningful difference to the health of patients in local communities.   Having a positive impact on a community’s health is a core decisive factor for the company’s charitable giving and community support.

      Back to top

    • Does previous support of a program by AstraZeneca guarantee future support?

      No. Each contribution request is evaluated on its own merits.

      Back to top

    • How does AstraZeneca ensure that contributions do not pose a conflict of interest with recipient organizations?

      AstraZeneca believes transparency and ethical behavior are critical components to advancing patient health, which is why we have policies and regulations that govern ethical behavior and required actions with non-profit organizations that must be adhered to by every employee.

      Back to top

    • Does AstraZeneca have a commitment to transparency in other areas besides contributions?

      Yes, making information available about our medical educational grants and contributions is the latest in a series of initiatives to enhance AstraZeneca’s openness with the public.  In addition, our U.S. business has either already shared or plans to share in the near future information on our clinical trials, policy positions, political contributions, and post-marketing study commitments.

      Back to top

Page tools

  • Print
  • Bookmark this page
  • Subscribe to RSS news feed

Related links

  • Request a contribution

AstraZeneca Hope Lodge

AstraZeneca Hope Lodge 

  • Learn more about the AstraZeneca Hope Lodge in Boston
  • Learn more about the AstraZeneca Hope Lodge in Philadelphia

Legal notices

  • Legal Information
  • Privacy Statement
  • © AstraZeneca 2009